Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.
Designed and made in Italy, the new HYPE sunglasses were debuted by the Red Bull – BORA – Hansgrohe team in October at the Il ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback